MirZyme Therapeutics achieves 93% preeclampsia risk detection with Imobisoft’s M-PREG platform
B2B Case Studies Featuring MirZyme Therapeutics as the Customer
Explore case studies featuring MirZyme Therapeutics as the customer — learn how vendors and partners helped MirZyme Therapeutics solve real business challenges.
MirZyme Therapeutics develops the M-PREG digital diagnostic platform, a cloud-based medical software product for identifying women at risk of preeclampsia.
Case Studies
Showing 1 Success Stories about Software and Services used by MirZyme Therapeutics
No matching case studies
